Bitmine (BMNR) Drops 12.6% on Ethereum Fall

Bitmine (BMNR) Drops 12.6% on Ethereum Fall

We recently published 10 Stocks Already Hurting in December. Bitmine Immersion Technologies, Inc. (NYSEAmerican:BMNR) is one of the top performers on Monday. Bitmine saw its share prices decline by 12.62 percent on Monday to close at $28.94 apiece as investor sentiment was dampened by Ethereum’s drop in prices on the same day. As of writing, Ethereum … Read more

Perma-Fix Environmental Services (PESI) Is Expecting $2M in Monthly Revenues in 2026

Perma-Fix Environmental Services (PESI) Is Expecting M in Monthly Revenues in 2026

Long Cast Advisers, an investment management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s cumulative net returns improved 4%. The fund returned a cumulative 266% net of fees, or 14% CAGR, since its inception in November 2015 through the quarter-end of … Read more

“We’re Going to Pass on That One Right Now as Much as I Like It”

“We’re Going to Pass on That One Right Now as Much as I Like It”

Brinker International, Inc. (NYSE:EAT) is one of the stocks Jim Cramer recently talked about. A caller inquired whether they should buy more, hold, or sell the stock, and Cramer replied: “Oh, you know what? I mentioned Brinker just this very morning when I was on Squawk on the Street, and now the stock is up … Read more

Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver

Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver

Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver On Novemb‍er 24, Truist’​s‍ Gregor‌y Ren⁠za in​itiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and se​t a price target of $14‌0, s‌lightly below th‌e … Read more

H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT

H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and  PT

With strong three-month performance and significant upside potential, Acrivon Therapeutics, Inc. (NASDAQ:ACRV) secures a spot on our list of the 12 hot penny stocks to invest in right now. H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT On November 25, 2025, Acrivon Therapeutics, Inc. (NASDAQ:ACRV) saw H.C. Wainwright’s Emily … Read more

×